BioCentury
ARTICLE | Financial News

APPX still climbing on Abraxane approval

January 10, 2005 8:00 AM UTC

American Pharmaceutical Partners (APPX) gained $11.01 (28%) to $49.72 on 13.3 million shares Monday after adding $4.78 (14%) to $38.71 on Friday when FDA approved its Abraxane to treat metastatic brea...